Get the Stockscreener App
120.90
4.59%
-5.6637
Davita Inc stock is traded at $120.90, with a volume of 1.29M.
It is down -4.59% in the last 24 hours and down -9.12% over the past month.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
See More
Previous Close:
$126.56
Open:
$124.87
24h Volume:
1.29M
Relative Volume:
1.64
Market Cap:
$8.62B
Revenue:
$12.82B
Net Income/Loss:
$936.34M
P/E Ratio:
11.26
EPS:
10.74
Net Cash Flow:
$1.47B
1W Performance:
-5.68%
1M Performance:
-9.12%
6M Performance:
-14.69%
1Y Performance:
-14.49%
1-Day Range:
$120.56
$128.40
1-Week Range:
$120.56
$130.82
52-Week Range:
$120.56
$179.60
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Compare DVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
120.58 | 9.05B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
468.40 | 109.60B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
209.55 | 18.38B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
26.77 | 15.79B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
220.86 | 14.34B | 16.08B | 1.20B | 1.06B | 17.82 |
|
EHC
Encompass Health Corp
|
118.81 | 12.65B | 5.51B | 494.70M | 386.40M | 4.84 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
Barclays Adjusts Price Target for DaVita (DVA), Maintains Equal-Weight Rating | DVA Stock News - GuruFocus
Davita Healthcare Partners stock hits 52-week low at $122.91 By Investing.com - Investing.com Nigeria
DaVita Inc. (NYSE:DVA) Q3 2025 Earnings Call Transcript - Insider Monkey
Is DaVita Inc. stock bottoming outJuly 2025 Rallies & AI Powered Market Entry Strategies - newser.com
Nisa Investment Advisors LLC Cuts Stock Position in DaVita Inc. $DVA - MarketBeat
Is DaVita Inc. stock safe for conservative investors2025 Top Gainers & Trade Opportunity Analysis - newser.com
Sumitomo Mitsui Trust Group Inc. Grows Position in DaVita Inc. $DVA - MarketBeat
Will DaVita Inc. rebound enough to break evenBuy Signal & Low Risk High Reward Ideas - newser.com
DaVita Inc. Reports Steady Q3 2025 Performance - TipRanks
Decoding DaVita Inc (DVA): A Strategic SWOT Insight - GuruFocus
DaVita HealthCare: Q3 Earnings Snapshot - Stamford Advocate
DaVita’s Profit Misses Mark As Costs And Volume Drop Bite - Finimize
DaVita (DVA) Reaffirms Full-Year Guidance Despite Challenges - GuruFocus
DaVita Delivers Steady Growth But Misses On Earnings - Finimize
Davita shares fall on weak earnings, Berkshire cuts stake further By Investing.com - Investing.com Canada
DaVita Q3 2025 Earnings: Revenue Up 4.8%, EPS Misses EstimatesNews and Statistics - IndexBox
DaVita misses quarterly profit estimates on rising costs, lower volumes - TradingView
DaVita (NYSE:DVA) Reports Q3 In Line With Expectations - TradingView
DaVita HealthCare (DVA) Q3 Earnings Lag Estimates - Yahoo Finance
DAVITA INC. SEC 10-Q Report - TradingView
DaVita Inc Reports Q3 Earnings: EPS of $2.04 Misses Estimates, Revenue at $3.42 Billion Slightly Below Expectations - GuruFocus
DaVita (DVA) Reports Q3 Revenue Slightly Below Expectations - GuruFocus
DaVita misses Q3 earnings estimates, maintains full-year outlook By Investing.com - Investing.com UK
Earnings Flash (DVA) DaVita Inc. Reports Q3 Revenue $3.42B, vs. FactSet Est of $3.435B - MarketScreener
DaVita misses Q3 earnings estimates, maintains full-year outlook - Investing.com
Earnings Flash (DVA) DaVita Inc. Posts Q3 Adjusted EPS $2.51 per Share, vs. FactSet Est of $3.22 - MarketScreener
DaVita Inc. 3rd Quarter 2025 Results - PR Newswire
DaVita Inc. (NYSE:DVA) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
How to integrate DaVita Inc. into portfolio analysis toolsBuy Signal & Momentum Based Trading Ideas - newser.com
Can DaVita Inc. (TRL) stock attract ESG investmentsEarnings Summary Report & Consistent Income Trade Recommendations - newser.com
Is DaVita Inc. stock gaining market share2025 Sector Review & Risk Managed Investment Strategies - Fundação Cultural do Pará
Truist Lowers PT on DaVita Inc. (DVA), Keeps a Hold Rating - MSN
Can Technology and Cost Discipline Lift DaVita's Q3 Earnings? - Nasdaq
Can DaVita Inc. stock beat market expectations this quarterWeekly Market Report & Safe Capital Preservation Plans - newser.com
Will DaVita Inc. stock outperform tech sector in 2025July 2025 Outlook & Daily Volume Surge Signals - newser.com
AustralianSuper Pty Ltd Buys 57,937 Shares of DaVita Inc. $DVA - MarketBeat
Will DaVita Inc. stock profit from fiscal stimulusNew Guidance & Expert Approved Momentum Trade Ideas - newser.com
Is DaVita Inc. stock trading at a premium valuationJuly 2025 Decliners & Momentum Based Trading Signals - newser.com
Is DaVita Inc. (TRL) stock safe for risk averse investorsQuarterly Risk Review & Smart Money Movement Alerts - newser.com
Is DaVita Inc. (TRL) stock testing key support2025 Winners & Losers & Verified Swing Trading Watchlists - newser.com
Can DaVita Inc. (TRL) stock retain market dominance2025 Macro Impact & Free Safe Entry Trade Signal Reports - newser.com
Can DaVita Inc. stock maintain operating marginsCPI Data & Stock Portfolio Risk Management - newser.com
DaVita (DVA) Reports Q3: Everything You Need To Know Ahead Of Earnings - FinancialContent
Custom strategy builders for tracking DaVita Inc.Market Rally & High Conviction Buy Zone Alerts - newser.com
Is a relief rally coming for DaVita Inc. holdersInsider Buying & Long-Term Capital Growth Strategies - newser.com
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):